These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 35998145)
61. Synthesis and biological evaluation of 4-biphenylamino-5-halo-2(5H)-furanones as potential anticancer agents. Wu YC; Luo SH; Mei WJ; Cao L; Wu HQ; Wang ZY Eur J Med Chem; 2017 Oct; 139():84-94. PubMed ID: 28800460 [TBL] [Abstract][Full Text] [Related]
62. Synthesis, antitumor activity and in silico analyses of amino acid derivatives of artepillin C, drupanin and baccharin from green propolis. Rodrigues DM; Portapilla GB; Silva GM; Duarte A; Rotta CG; da Silva CHTP; de Albuquerque S; Bastos JK; Campo VL Bioorg Med Chem; 2021 Oct; 47():116372. PubMed ID: 34454129 [TBL] [Abstract][Full Text] [Related]
63. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER. Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119 [TBL] [Abstract][Full Text] [Related]
64. Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents. Wu GR; Xu B; Yang YQ; Zhang XY; Fang K; Ma T; Wang H; Xue NN; Chen M; Guo WB; Jia XH; Wang PL; Lei HM Eur J Med Chem; 2018 Jul; 155():183-196. PubMed ID: 29886322 [TBL] [Abstract][Full Text] [Related]
65. Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors. Ali IH; Abdel-Mohsen HT; Mounier MM; Abo-Elfadl MT; El Kerdawy AM; Ghannam IAY Bioorg Chem; 2022 Sep; 126():105883. PubMed ID: 35636123 [TBL] [Abstract][Full Text] [Related]
66. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents. Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819 [TBL] [Abstract][Full Text] [Related]
67. Synthesis, anticancer activity and molecular docking studies of N-deacetylthiocolchicine and 4-iodo-N-deacetylthiocolchicine derivatives. Klejborowska G; Urbaniak A; Maj E; Wietrzyk J; Moshari M; Preto J; Tuszynski JA; Chambers TC; Huczyński A Bioorg Med Chem; 2021 Feb; 32():116014. PubMed ID: 33465696 [TBL] [Abstract][Full Text] [Related]
68. Steroidal N-Sulfonylimidates: Synthesis and biological evaluation in breast cancer cells. Volkova YA; Kozlov AS; Kolokolova MK; Uvarov DY; Gorbatov SA; Andreeva OE; Scherbakov AM; Zavarzin IV Eur J Med Chem; 2019 Oct; 179():694-706. PubMed ID: 31284080 [TBL] [Abstract][Full Text] [Related]
69. Anticancer potential of novel α,β-unsaturated γ-lactam derivatives targeting the PI3K/AKT signaling pathway. Brindisi M; Frattaruolo L; Mancuso R; Palumbo Piccionello A; Ziccarelli I; Catto M; Nicolotti O; Altomare CD; Gabriele B; Cappello AR Biochem Pharmacol; 2021 Aug; 190():114659. PubMed ID: 34147489 [TBL] [Abstract][Full Text] [Related]
70. In vitro biological and in silico molecular docking and ADME studies of a substituted triazine-coordinated cadmium(II) ion: efficient cytotoxicity, apoptosis, genotoxicity, and nuclease-like activity plus binding affinity towards apoptosis-related proteins. Anjomshoa M; Sahihi M; Fatemi SJ; Shayegan S; Farsinejad A; Amirheidari B Biometals; 2022 Jun; 35(3):549-572. PubMed ID: 35366135 [TBL] [Abstract][Full Text] [Related]
71. Design, Synthesis, Matada GSP; Abbas N; Dhiwar PS; Basu R; Devasahayam G Anticancer Agents Med Chem; 2021; 21(4):451-461. PubMed ID: 32698735 [TBL] [Abstract][Full Text] [Related]
72. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators. Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307 [TBL] [Abstract][Full Text] [Related]
73. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells]. Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477 [TBL] [Abstract][Full Text] [Related]
74. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer. Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326 [TBL] [Abstract][Full Text] [Related]
75. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines. Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511 [TBL] [Abstract][Full Text] [Related]
76. "Click" reaction mediated synthesis of costunolide and dehydrocostuslactone derivatives and evaluation of their cytotoxic activity. Pavan Kumar Ch; Devi A; Ashok Yadav P; Rao Vadaparthi R; Shankaraiah G; Sowjanya P; Jain N; Suresh Babu K J Asian Nat Prod Res; 2016 Nov; 18(11):1063-78. PubMed ID: 27329166 [TBL] [Abstract][Full Text] [Related]
78. Anti-tumor properties of methoxylated analogues of resveratrol in malignant MCF-7 but not in non-tumorigenic MCF-10A mammary epithelial cell lines. van den Brand AD; Villevoye J; Nijmeijer SM; van den Berg M; van Duursen MBM Toxicology; 2019 Jun; 422():35-43. PubMed ID: 31004704 [TBL] [Abstract][Full Text] [Related]
79. Synthesis of novel forskolin isoxazole derivatives with potent anti-cancer activity against breast cancer cell lines. Burra S; Voora V; Rao CP; Vijay Kumar P; Kancha RK; David Krupadanam GL Bioorg Med Chem Lett; 2017 Sep; 27(18):4314-4318. PubMed ID: 28838692 [TBL] [Abstract][Full Text] [Related]